Plasma 24S-hydroxycholesterol-Reference-Cited by-同舟云学术

Plasma 24S-hydroxycholesterol

Published:2000-06 Issue:9 Volume:11 Page:1959-1962
ISSN:0959-4965
Container-title:NeuroReport
language:en
Short-container-title:NeuroReport

Author:

Papassotiropoulos Andreas,Lütjohann Dieter,Bagli Metin,Locatelli Sandra,Jessen Frank,Rao Marie Luise,Maier Wolfgang,Bjürkhem Ingemar,von Bergmann Klaus,Heun Reinhard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Neuroscience

Reference8 articles.

1. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

2. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans

3. The current status of Apo E4 as a risk factor for Alzheimer's disease: an epidemiological perspective

4. “Mini-mental state”

5. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neurons;Neurobiology of Disease;2024-08

2. Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease;Clinical and Translational Science;2024-07

3. Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis;Journal of Alzheimer's Disease;2024-04-16

4. Plasma oxysterols are associated with serum lipids and dementia risk in older women;Alzheimer's & Dementia;2024-04-04

5. Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development;Brain;2024-02-01